CStone’s Anti-CTLA-4 Antibody CS1002 Filed for Clinical Trial Approval in Australia Dec 29, 2017 Life Science
Shanghai Henlius Announces $192.5 Million Funding for Biosimilars, Novel mAbs Dec 29, 2017 Life Science
Cellular Biomedicine Group Announces Closing of $14.5M Private Placement Offering Dec 28, 2017 Life Science
Shanghai’s SARI to Acquire NMS, an Italian Oncology Company, for $359 Million Dec 28, 2017 Life Science